#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile idiopathic arthritis Lip and/or oral cavity cancer Pleural mesothelioma Mucopolysaccharidosis II Liposarcoma metastatic Paroxysmal nocturnal haemoglobinuria Ataxia telangiectasia Cryoglobulinaemia Mantle cell lymphoma recurrent Acute lymphocytic leukaemia recurrent Chronic inflammatory demyelinating polyradiculoneuropathy Angiosarcoma metastatic Ductal adenocarcinoma of pancreas Mantle cell lymphoma stage II Alveolar rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Angiosarcoma – Diagnostics Lennox-Gastaut syndrome – Basic Information Undifferentiated sarcoma – Trials in Disease Glycogen storage disease type V – Diagnostics Familial amyotrophic lateral sclerosis – Basic Information Glycogen storage disease type V Ewing’s sarcoma recurrent – Diagnostics Haemolytic uraemic syndrome – Diagnostics Mast cell activation syndrome – Trials in Disease Hereditary ataxia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pentixafor Gallium Ga-68 Clofarabine Air, Medicinal Vinorelbine Tartrate Fulvestrant Relatlimab Vh4524184 Montelukast Sodium Caba-201 Rbl012.2 Palopegteriparatide Calcium Levofolinate Technetium (99Mtc) Tiratricol Ambrosia Artemisiifolia (302) Disulfiram Neflamapimod RO7837195 Elexacaftor Axitinib More therapies…

    Learn about Your Condition

    Cholecystitis acute Erosive oesophagitis Diabetic foot infection Genital herpes Renal transplant Lichenoid keratosis Metastases to peritoneum Choroidal dystrophy Papillary thyroid cancer Genitourinary tract neoplasm Eclampsia Essential hypertension Acarodermatitis Benign renal neoplasm Hypoparathyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Head and neck cancer

  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    • Malignant melanoma
    • Renal cell carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Durvalumab
    • Ipilimumab
    Hungary

  • Study of Mitazalimab Injection Treatment for Patients with High-Risk Oral Potentially Malignant Disorders

    Recruiting

    2 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Mitazalimab
    Italy

  • Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • HER2 mutant non-small cell lung cancer
    • Sarcoma
    • Head and neck cancer
    Investigated Drugs:
    • Zanidatamab
    France

  • Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • HAFNIUM OXIDE
    • Cetuximab
    Austria Belgium Czechia France Germany Greece +4

  • Study on the Impact of Cisplatin and Drug Combination on Speech and Cognition in Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Testis cancer
    • Head and neck cancer
    Investigated Drugs:
    • Bleomycin Sulfate Ph. Eur.
    • Mesna
    • Ifosfamide
    Finland

  • Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    • Malignant melanoma
    • Breast cancer
    Investigated Drugs:
    • Perflubutane
    The Netherlands
1 2 3 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!